Latest News of ARQT
Arcutis Biotherapeutics, Inc (ARQT): A Small-Cap Leader in Skin Disease Treatments
By Yahoo! Finance |
1 month ago
Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) is a top small-cap stock with high potential, leading the list of promising investments due to its innovative dermatological treatments and strong financia...
Insider Selling: Director Howard Welgus Sells 10,000 Shares of Arcutis Biotherapeutics Inc (ARQT)
By Yahoo! Finance |
2 months ago
Arcutis Biotherapeutics Inc is a biopharmaceutical company focusing on dermatological treatments. Insider selling trends, with 21 sales and 2 buys in the past year, reflect a valuation of $1.27 billio...
Arcutis Biotherapeutics, Inc. (ARQT): This Small-Cap Healthcare Stock Is A Good Buy Right Now
By Yahoo! Finance |
2 months ago
Arcutis Biotherapeutics Inc (NASDAQ:ARQT) is a promising small-cap healthcare stock focused on dermatological treatments. Its lead product, ZORYVE, shows market potential, with hedge fund interest and...
-
Analysts Expect Breakeven For Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Before Long
By Yahoo! Finance | 3 months agoArcutis Biotherapeutics is close to breaking even, with analysts predicting profitability in 2026. However, its high debt level raises investment risk. The company's growth prospects and path to profi...